GobblesGobbles

Aging as a Broken Record: Sinclair's Information Theory of Getting Old

3 min readPublishes every 2 days3 sourcesAI-written, source-linked. Learn moreNot medical advice. Talk to your doctor before changing care.

Aging as a Broken Record: Sinclair's Information Theory of Getting Old

One of the world's leading longevity researchers has spent over 30 years chasing a single bold idea: aging is less about damaged DNA and more about lost epigenetic information. The cells still hold the code. The instructions just get scrambled over time—like a scratched record losing the song. If a backup copy can be restored, aging starts to look a lot less inevitable.

Gobbles Gobble's Take: If aging is an information problem, the repair bill just got a lot more interesting than the funeral bill. Source: Perplexity Search (community news)


NAD: Longevity Molecule or Very Expensive Recliner Time?

NAD therapy is having its moment—tucked between Pilates studios and juice bars, promising cellular optimization in softly backlit lettering. The molecule itself is no joke: it sits at the center of energy metabolism, DNA repair, inflammation, and cellular decision-making, and it activates sirtuins, which is why it keeps showing up in longevity circles. But the core question remains stubbornly open: does NAD therapy actually hold up as a longevity intervention, or has wellness culture simply learned to charge a premium for sitting in a chair?

Gobbles Gobble's Take: When a molecule becomes a status symbol, the science better be wearing a name tag. Source: Perplexity Search (community news)


The Centenarian Cheat Code: FOXO3 and Engineered Stem Cells

Longevity researchers have long wondered what centenarians carry that the rest of us don't. FOXO3 keeps coming up. In a 2025 study, a team led by Guang-Hui Liu at the Chinese Academy of Sciences engineered human stem cells with a constantly active form of FOXO3, then infused them into elderly macaques every two weeks for 44 weeks. The results were striking: better memory-task performance, denser bone, restored reproductive markers, and aging clocks that ran backward across many tissues. The researchers are clear-eyed about it—initial evidence, not a finished therapy. That distinction matters. So does the result.

Gobbles Gobble's Take: A big result, a careful footnote, and a very long runway. That's not a disappointment—that's how real progress sounds. Source: Perplexity Search (community news)


In Case You Missed It

Yesterday's top stories:

Was this briefing useful?

One tap helps Gobbles learn what to cover more carefully.

Get Longevity Lab in your inbox

Free daily briefing. No spam. Unsubscribe anytime.

See something wrong? Report an inaccuracy